https://www.selleckchem.com/pr....oducts/pkm2-inhibito
Disturbance of consciousness during the first month was the only independent predictor (OR 2.91, 95% CI 1.27-6.65; = 0.01) of a poor functional neurologic outcome. Overall, 15.9% of the patients had one or multiple relapses, with 82.0% experiencing the first relapse within 24 months and 76.9% experiencing relapses that were less severe than the initial episodes. Relapse-related risk factors included the female sex and delayed treatment ( 0.05). Most patients achieved favorable long-term functional outcomes. Some